Clinical Trials Directory

Trials / Completed

CompletedNCT04240379

Metacognition Assessment in Patient With Multiple Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study will assessed the level of consciousness of MS patients suffering of cognitive and motor disorders. Understanding the awareness of the disease is crucial to allow better management of these patients. It has been shown, for other neurological pathologies, that a lack of awareness of deficits leads to inefficient rehabilitation and a disorder of understanding the impact of deficits in daily activities. Metacognition could be altered with age, so we will include participants between 18 and 60 years old.

Detailed description

Subject who have to do neurological assessement by the Multiple sclerosis Functional Composite (MSFC) will be enrolled. The patient will estimate the time to undergo the test. This time will be compared to the time really make by the patient to realise test.

Conditions

Timeline

Start date
2020-06-11
Primary completion
2022-04-08
Completion
2022-04-08
First posted
2020-01-27
Last updated
2022-06-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04240379. Inclusion in this directory is not an endorsement.

Metacognition Assessment in Patient With Multiple Sclerosis (NCT04240379) · Clinical Trials Directory